ZURICH / LONDON (IT BOLTWISE) – Novartis shares recorded slight price losses in the morning, although the pharmaceutical company recently presented a positive quarterly balance sheet. Earnings per share increased compared to the previous year, and sales also increased slightly. Analysts still see potential for further price increases.

Today’s daily deals at Amazon! ˗ˋˏ$ˎˊ˗

Novartis shares showed slight price losses in the morning, although the pharmaceutical company recently presented a positive quarterly balance sheet. In SIX SX trading, the price fell by 0.1 percent to CHF 101.80. In the meantime, the share reached a daily low of CHF 101.68. The trading day started at a price of CHF 101.76 and to date 64,921 shares have been traded.

On October 9, 2025, Novartis shares reached a 52-week high of CHF 106.88, which corresponds to a price increase of 4.99 percent. In contrast, the price fell to a 52-week low of CHF 81.10 on April 9, 2025. The current price is 25.52 percent above this low point. Analysts estimate the price target on average to be CHF 100.38, which indicates further potential.

Novartis’ most recent financial conference on October 28, 2025 revealed an increase in earnings per share to CHF 1.63, compared to CHF 1.37 in the same quarter of the previous year. Sales rose by 0.19 percent to 11.13 billion CHF. These figures illustrate the company’s stable financial position, which continues to show growth potential despite the current price losses.

A dividend of USD 4.21 is expected for the current year, after a profit share of CHF 3.50 was distributed in 2024. Experts forecast earnings of $8.93 per share in 2025. The publication of the Q4 2025 balance sheet is scheduled for February 4, 2026, while the presentation of the Q4 2026 balance sheet is scheduled for February 3, 2027.


Order an Amazon credit card without an annual fee with a credit limit of 2,000 euros!

Bestseller No. 1 ᵃ⤻ᶻ “KI Gadgets”

Bestseller No. 2 ᵃ⤻ᶻ “KI Gadgets”

Bestseller No. 3 ᵃ⤻ᶻ “KI Gadgets”

Bestseller No. 4 ᵃ⤻ᶻ “KI Gadgets”

Bestseller No. 5 ᵃ⤻ᶻ “KI Gadgets”

Did you like the article or the news - Novartis shares: price losses despite a strong balance sheet? Then subscribe to us on Insta: AI News, Tech Trends & Robotics - Instagram - Boltwise

Our KI morning newsletter “The KI News Espresso” with the best AI news of the last day free by email – without advertising: Register here for free!




Novartis shares: price losses despite strong balance sheet
Novartis shares: price losses despite strong balance sheet (Photo: DALL-E, IT BOLTWISE)

Please send any additions and information to the editorial team by email to de-info[at]it-boltwise.de. Since we cannot rule out AI hallucinations, which rarely occur with AI-generated news and content, we ask you to contact us via email and inform us in the event of false statements or misinformation. Please don’t forget to include the article headline in the email: “Novartis share: price losses despite strong balance sheet”.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *